top of page

Anchor 1

Ideas. Insights. Impact.

Explore perspectives, updates, and strategic thinking that shape how we approach healthcare growth.

Search

Patient-Powered Growth: How Demand Generation Beats Supply Push in Underserved Markets

Patient-Powered Growth: How Demand Generation Beats Supply Push in Underserved Markets

Patient-Powered Growth: How Demand Generation Beats Supply Push in Underserved Markets

Inderjit Sood

Jul 167 min read

Field Force 2.0: The 5 Non-Negotiable Traits of High-Performing Teams in India's Heartland

Field Force 2.0: The 5 Non-Negotiable Traits of High-Performing Teams in India's Heartland

Field Force 2.0: The 5 Non-Negotiable Traits of High-Performing Teams in India's Heartland

Inderjit Sood

Jul 166 min read

The Chemist Revolution: How Retail Pharmacists Drive 60% of Treatment Decisions in Semi-Urban India

The Chemist Revolution: How Retail Pharmacists Drive 60% of Treatment Decisions in Semi-Urban India

The Chemist Revolution: How Retail Pharmacists Drive 60% of Treatment Decisions in Semi-Urban India

Inderjit Sood

Jul 166 min read

The $8 Billion Blind Spot: Why Big Pharma Keeps Losing to Local Players in Tier 2 Markets

The $8 Billion Blind Spot: Why Big Pharma Keeps Losing to Local Players in Tier 2 Markets

The $8 Billion Blind Spot: Why Big Pharma Keeps Losing to Local Players in Tier 2 Markets

Inderjit Sood

Jul 165 min read

Rural India ROI: The Secret Strategy Delivering 40% Higher Margins Than Metro Markets

Rural India ROI: The Secret Strategy Delivering 40% Higher Margins Than Metro Markets

Rural India ROI: The Secret Strategy Delivering 40% Higher Margins Than Metro Markets

Inderjit Sood

Jul 166 min read

Stop Chasing Unicorns: How Mature Brands Are Outperforming New Launches 3-to-1

Stop Chasing Unicorns: How Mature Brands Are Outperforming New Launches 3-to-1

Stop Chasing Unicorns: How Mature Brands Are Outperforming New Launches 3-to-1

Inderjit Sood

Jul 166 min read

The $15 Billion Opportunity Big Pharma Is Missing: Why Tier 3 Markets Will Define the Next Decade

The $15 Billion Opportunity Big Pharma Is Missing: Why Tier 3 Markets Will Define the Next Decade

The $15 Billion Opportunity Big Pharma Is Missing: Why Tier 3 Markets Will Define the Next Decade

Inderjit Sood

Jul 165 min read

Why Tier 3 Markets Are Pharma's Next Growth Engine, and How to Win There

Why Tier 3 Markets Are Pharma's Next Growth Engine, and How to Win There

Why Tier 3 Markets Are Pharma's Next Growth Engine, and How to Win There

Inderjit Sood

Jul 165 min read

What to Include in a Tail-End Brand Revitalization Business Case

Inderjit Sood

Jul 162 min read

Managing the Last Mile: How Smart Delivery Keeps Your Brands Alive

Managing the Last Mile: How Smart Delivery Keeps Your Brands Alive

Managing the Last Mile: How Smart Delivery Keeps Your Brands Alive

Inderjit Sood

Jul 163 min read

Tracking the Right KPIs for Brand Revitalization: What Pharma Leaders Must Know

Inderjit Sood

Jul 15 min read

Building Field Teams That Actually Perform: Lessons from India's Heartland

Building Field Teams That Actually Perform: Lessons from India's Heartland

Building Field Teams That Actually Perform: Lessons from India's Heartland

Inderjit Sood

Jun 225 min read

The Chemist Is the New Influencer: Rethinking Stakeholder Strategy in Semi-Urban Markets

The Chemist Is the New Influencer: Rethinking Stakeholder Strategy in Semi-Urban Markets

The Chemist Is the New Influencer: Rethinking Stakeholder Strategy in Semi-Urban Markets

Inderjit Sood

Jun 205 min read

5 Myths About Tail-End Brand Performance—And What the Data Really Says

Inderjit Sood

Jun 174 min read

When Mature Brands Plateau: What Top Pharma Teams Do Next

When Mature Brands Plateau: What Top Pharma Teams Do Next

When Mature Brands Plateau: What Top Pharma Teams Do Next

Inderjit Sood

Jun 173 min read

Tail-End Brands and Tier 3 Markets: A Match Pharma Has Overlooked for Too Long

Tail-End Brands and Tier 3 Markets: A Match Pharma Has Overlooked for Too Long

Tail-End Brands and Tier 3 Markets: A Match Pharma Has Overlooked for Too Long

Inderjit Sood

Jun 163 min read

How to Run a Controlled Relaunch Without Internal Disruption

How to Run a Controlled Relaunch Without Internal Disruption

How to Run a Controlled Relaunch Without Internal Disruption

Inderjit Sood

Jun 163 min read

When to Sunset and When to Scale: A Strategic Checklist for Tail-End Brands

When to Sunset and When to Scale: A Strategic Checklist for Tail-End Brands

When to Sunset and When to Scale: A Strategic Checklist for Tail-End Brands

Inderjit Sood

Jun 163 min read

Plan B for Pharma: A Proven Model to Maximize Mature Brand ROI in Rural India

Inderjit Sood

Jun 165 min read

Turning Cost Centers into Quiet Winners: A New Approach to Brand Retirement

Inderjit Sood

Jun 153 min read

Connect with us

bottom of page